<DOC>
	<DOCNO>NCT00822406</DOCNO>
	<brief_summary>A total 41 adult perennial allergic rhinitis enrol first double-blind placebo-controlled phase six month , treat weekly basis sublingual dose single individualized homeopathic medicine placebo . After closed initial phase , patient invited participate long-term open-label control phase , would receive homeopathic treatment maximum period 36 month , result compare improvement initial phase . Signs symptoms score , rescue medication requirement quality life assess questionnaire personal clinical evaluation independent researcher , phase . Primary secondary clinical outcome , respectively , specific general allergic sign symptoms score . Total IgE title perform phase .</brief_summary>
	<brief_title>Effectiveness Individualized Homeopathic Treatment Perennial Allergic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<criteria>moderate rhinitis assign write informed consent chronic disease corticosteroid use pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>allergy</keyword>
	<keyword>rhinitis</keyword>
	<keyword>homeopathy</keyword>
	<keyword>double-blind</keyword>
</DOC>